Despite promising clinical outcomes from the first-ever gene therapy trial for Huntington’s Disease (HD), a leading expert involved in the…
Read More
Expert Insights Emerge on First Successful Huntington’s Disease Gene Therapy Trial Amidst FDA Challenges
Science News: Empowering Public Understanding of Science, Medicine, and Technology Since 1921
Science News, a venerable institution dedicated to disseminating accurate and accessible information on scientific advancements, has been a cornerstone of…
Read More
Goose Takes Flight: How Agentic Coding is Revolutionizing Developer Workflows and Data Science Productivity
The landscape of artificial intelligence applied to software development is undergoing a profound transformation, moving beyond mere code suggestions to…
Read More
Borneo’s Cryptic Frogs: Unraveling the Complexities of Species Discovery in a Digital Age
The romanticized image of intrepid explorers venturing into uncharted territories to discover new species, while enduringly popular, often belies the…
Read More
TWiV 1284: Clinical update with Dr. Daniel Griffin
In a comprehensive clinical update delivered shortly after the New Year’s festivities, Dr. Daniel Griffin, alongside Vincent Racaniello, provided a…
Read More
Breakthrough Study Reveals Synergistic Drug Combination to Overcome Differentiation Blockade in Acute Myelogenous Leukemia
In a landmark advancement for hematologic oncology, researchers from Ludwig Cancer Research have unveiled a novel therapeutic strategy aimed at…
Read More
Bugs deliver drugs: weaponizing bacteria to target colorectal cancer therapy
A groundbreaking scientific endeavor, spearheaded by a collaborative team of researchers from Baylor University (TX, USA), Texas Tech University Health…
Read More
Eli Lilly’s Triple Agonist Achieves 16.8% Weight Loss in Phase 3 Trial for Type 2 Diabetes, Signaling Major Therapeutic Advance
Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Houston Methodist Researchers Identify TDP43 Protein as a Key Regulator of DNA Mismatch Repair Linking Neurodegeneration and Cancer
In a landmark study that bridges two historically distinct fields of medicine, researchers at the Houston Methodist Research Institute have…
Read More
Scientists from The University of Manchester Identify New Subatomic Particle Xi-cc-plus at CERNs Large Hadron Collider
The international scientific community has reached a significant milestone in the field of high-energy physics with the discovery of a…
Read MoreYOU MAY HAVE MISSED
